Mutual Funds that own 4SC AG
Apus Capital Revalue Fonds
157,143
0.51%
157,143
0.4%
09/30/2017
85,000
0.28%
-50,000
0.21%
05/31/2018
USAA International Fund
69,866
0.23%
0
0.01%
06/30/2018
Plutos - Multi Chance Fund
50,000
0.16%
50,000
1.07%
09/30/2017
| Address |
Fraunhoferstrasse 22
Planegg-Martinsried Bayern (Bavaria) 82152
Germany
|
|
Employees
|
- |
| Website |
http://www.4sc.de |
| Updated |
07/08/2019 |
| 4SC AG engages in the development of small molecule drugs that targets cancer through epigenetic mechanisms. It also involves in the preclinical and clinical development of its products. Its assets are resminostat, 4SC-202, and 4SC-208. |
